HaemoCerTM Application in Breast Cancer Surgery

NACompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions

Breast Neoplasm FemaleMastectomy, Segmental

Interventions

OTHER

HaemoCer

Randomized application of 3g haemostatic powder (HaemoCer) in the wound site during breast-conserving surgery.

Trial Locations (1)

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT04811378 - HaemoCerTM Application in Breast Cancer Surgery | Biotech Hunter | Biotech Hunter